STAT3 and neoplasm: Legumain targeted nanoparticles encapsulating hydrazinocurcumin suppressed STAT3 and re-educated TAMs, to be IL-12high, IL-10low and TGF-βlow, which resulted in suppression of tumor growth, metastasis and angiogenesis in vivo [160].